Drug intelligence / Profile preview

Accordion Pill Zaleplon

Development stage
Approved
Lead developer
Decoy Biosystems
Modality
Small Molecules
Administration
Oral
01

Overview

Accordion Pill Zaleplon is an oral, extended-release formulation of the nonbenzodiazepine hypnotic zaleplon, engineered using the “Accordion Pill” gastric-retentive delivery platform to prolong residence in the stomach and provide a more sustained zaleplon plasma profile compared with immediate-release capsules. Zaleplon is a pyrazolopyrimidine sedative-hypnotic that selectively modulates the gamma-aminobutyric acid type A (GABAA) receptor complex at the benzodiazepine omega-1 (BZ1) site on the alpha subunit, enhancing GABAergic inhibitory neurotransmission to promote sleep onset in patients with insomnia.[3][5] The Accordion Pill technology uses layered, expandable polymeric films that unfold in the stomach to release zaleplon gradually, with the goal of improving sleep maintenance while limiting next-morning residual effects relative to higher-dose immediate-release zaleplon.

Brand names
Sonata
Other names
AP-ZPIN 10 003IN10 003IN-10 003Accordion Pill-Zaleplon
02

Targets

BZD site (GABA-A receptor benzodiazepine site)

Beyond the preview

Go deeper on Accordion Pill Zaleplon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accordion Pill Zaleplon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call